10
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      Are you tired of sifting through news that doesn't interest you?
      Personalize your Karger newsletter today and get only the news that matters to you!

      Sign up

      • Record: found
      • Abstract: found
      • Article: found

      EOG and ERG Components in Ischemic Retinopathy

      research-article
      ,
      Ophthalmic Research
      S. Karger AG
      Ischemic retinopathy, Electrooculography, Electroretinography

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In 12 adult subjects with ischemic retinopathy and in 2 children with surgically dissected retinal artery EOG light peaks and dark troughs were recorded. Standing potentials, light-induced potentials and dark troughs were reduced significantly in all affected eyes. Standing potential, light-induced oscillation and dark oscillation do not only depend upon the pigment epithelium/receptor unit; the integrity of the inner retinal structures is also of significance. The analysis of slow EOG components alone does not allow to localize and determine the level of retinal defects.

          Related collections

          Author and article information

          Journal
          ORE
          Ophthalmic Res
          10.1159/issn.0030-3747
          Ophthalmic Research
          S. Karger AG
          0030-3747
          1423-0259
          1977
          1977
          03 December 2009
          : 9
          : 1
          : 38-46
          Affiliations
          2nd Eye Department, University of Vienna (Director: Prof. H. Slezak), Vienna
          Article
          264865 Ophthalmic Res 1977;9:38–46
          10.1159/000264865
          88be3285-61c9-4103-b1ae-c32b9500e368
          © 1977 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 01 November 1976
          : 11 February 1977
          Page count
          Pages: 9
          Categories
          Paper

          Vision sciences,Ophthalmology & Optometry,Pathology
          Electroretinography,Ischemic retinopathy,Electrooculography

          Comments

          Comment on this article